Evaluation of non-invasive prenatal RHD genotyping of the fetus

Medical Journal of Australia

Volumn 191, Issue 1, 2009, Pages 21-25

  Hyland, Catherine A ^a   Gardener, Glenn J ^b   Davies, Helen ^a   Ahvenainen, Minna ^a   Flower, Robert L ^a   Irwin, Darryl ^c   Morris, Jonathan M ^d   Ward, Christopher M ^e   Hyett, Jonathan A ^f  

^a AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^b MATER HOSPITAL   (Australia)

^c Sequenom Asia Pacific   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e ROYAL NORTH SHORE HOSPITAL   (Australia)

^f ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; RHO(D) ANTIGEN;

ACCURACY; ARTICLE; AUSTRALIA; BLOOD GROUP RHESUS SYSTEM; BLOOD SAMPLING; CONTROLLED STUDY; DNA EXTRACTION; DNA METHYLATION; EVALUATION RESEARCH; EXON; FALSE NEGATIVE RESULT; FEMALE; GENE AMPLIFICATION; GENOTYPE; HUMAN; MATERNAL PLASMA; NON INVASIVE PROCEDURE; PRENATAL CARE; PRENATAL DIAGNOSIS; QUALITY CONTROL; SEROTYPE; TERTIARY HEALTH CARE; VENOUS BLOOD; ADULT; BLOOD; COHORT ANALYSIS; FETOMATERNAL TRANSFUSION; FETUS DISEASE; GENETICS; HEALTH CARE QUALITY; METHODOLOGY; ORGANIZATION AND MANAGEMENT; PREGNANCY; PROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

ADULT; COHORT STUDIES; DNA; EXONS; FEMALE; FETAL DISEASES; GENOTYPE; HUMANS; MATERNAL-FETAL EXCHANGE; PREGNANCY; PRENATAL CARE; PRENATAL DIAGNOSIS; PROSPECTIVE STUDIES; QUALITY ASSURANCE, HEALTH CARE; QUEENSLAND; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RH-HR BLOOD-GROUP SYSTEM; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 69249236998     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2009.tb02668.x     Document Type: Article

References (25)

1. Clarke CA, Whitfield AG, Mollison PL. Deaths from Rh haemolytic disease in England and Wales in 1984 and 1985. BMJ 1987; 294: 1001.
2. Robson SC, Lee D, Urbaniak S. Anti-D immunoglobulin in RhD prophylaxis. Br J Obstet Gynaecol 1998; 105: 129-134.
3. Schumacher B, Moise KJ Jr. Fetal transfusion for red blood cell alloimmunization in pregnancy. Obstet Gynecol 1996; 88: 137-150. (Pubitemid 26197293)
4. Tabor A, Philip J, Madsen M, et al. Randomised controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet 1986; 1: 1287-1293.
5. Tabor A, Bang J, Nørgaard-Pedersen B. Fetomaternal haemorrhage associated with genetic amniocentesis: results of a randomized trial. Br J Obstet Gynaecol 1987; 94: 528-534. (Pubitemid 17077761)
6. Bennet PR, Le Van Kim C, Colin Y, et al. Prenatal determination of fetal RhD type by DNA amplification. N Engl J Med 1993; 329: 607-610. (Pubitemid 23244811)
7. Chan FY, Cowley NM, Wolter L, et al. Prenatal RHD gene determination and dosage analysis by PCR: clinical evaluation. Prenat Diagn 2001; 21: 321-326. (Pubitemid 32417222)
8. Lo YMD, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997; 350: 485-487. (Pubitemid 27343304)
9. Lo YMD, Hjelm MN, Fidler C, et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 1998; 339: 1734-1738. (Pubitemid 28555431)
10. Finning K, Martin P, Daniels G. A clinical service in the UK to predict fetal Rh (Rhesus) D blood group using free fetal DNA in maternal plasma. Ann N Y Acad Sci 2004; 1022: 119-123. (Pubitemid 38951591)
11. Finning KM, Martin PG, Soothill PW, Avent ND. Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service. Transfusion 2002; 42: 1079-1085.
12. Rouillac-Le Sciellour C, Puillandre P, Gillot R, et al. Large-scale pre-diagnosis study of fetal RHD genotyping by PCR on plasma DNA from RhD-negative pregnant women. Mol Diagn 2004; 8: 23-31. (Pubitemid 38989470)
13. Bianchi DW, Avent ND, Costa JM, van der Schoot CE. Noninvasive prenatal diagnosis of fetal Rhesus D: ready for Prime(r) Time. Obstet Gynecol 2005; 106: 841-844.
14. Geifman-Holtzman O, Grotegut CA, Gaughan JP. Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood - a meta-analysis. Am J Obstet Gynecol 2006; 195: 1163-1173. (Pubitemid 44415679)
15. Nelson M, Eagle C, Langshaw M, et al. Genotyping fetal DNA by non-invasive means: extraction from maternal plasma. Vox Sang 2001; 80: 112-116. (Pubitemid 35345782)
16. Chan KCA, Ding C, Gerovassili A, et al. Hypermethylated RASSF1A in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem 2006; 52: 2211-2218. (Pubitemid 44924994)
17. Mison L, Seed CR, Margaritis AR, Hyland C. Nucleic acid technology screening of Australian blood donors for hepatitis C and human immunodeficiency virus-1 RNA: comparison of two high-throughput testing strategies. Vox Sang 2003; 84: 11-19. (Pubitemid 36564981)
18. Scientific Subcommittee of the Australian and New Zealand Society of Blood Transfusion. Guidelines for pretransfusion testing. 4th ed. Sydney: ANZSBT, 2002.
19. Hyland CA, Wolter LC, Saul A. Three unrelated Rh D gene polymorphisms identified among blood donors with Rhesus CCee (r'r') phenotypes. Blood 1994; 84: 321-324. (Pubitemid 24193837)
20. Wagner FF, Flegel WA. Review: the molecular basis of the Rh blood group phenotypes. Immunohematology 2004; 20: 23-36. (Pubitemid 38292745)
21. Westhoff CM. The Rh blood group system in review: a new face for the next decade. Transfusion 2004; 44: 1663-1673. (Pubitemid 39431288)
22. Reynisson E, Josefsen MH, Krause M, Hoorfar J. Evaluation of probe chemistries and platforms to improve the detection limit of real-time PCR. J Microbiol Methods 2006; 66: 206-216. (Pubitemid 43903028)
23. Finning K, Martin P, Summers J, et al. Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study. BMJ 2008; 336: 816-818. (Pubitemid 351548224)
24. Chan KCA, Lai PBS, Mok TSK, et al. Quantitative analysis of circulating methylated DNA as a biomarker for hepatocellular carcinoma. Clin Chem 2008; 54: 1528-1536.
25. Hyett JA, Gardener G, Stojilkovic-Mikic T, et al. Reduction in diagnostic and therapeutic interventions by non-invasive determination of fetal sex in early pregnancy. Prenat Diagn 2005; 25: 1111-1116. (Pubitemid 43016291)